View Older Stories

May 20, 2021 08:00AM Chiasma to Present Encore and New Data from MPOWERED™ Phase 3 Trial at Upcoming e-ECE and AACE Virtual Conferences

May 13, 2021 04:00PM Acentrus Specialty Contracts with Chiasma to Bring MYCAPSSA® (octreotide) to Health Systems and Hospitals in the Acentrus Network

May 5, 2021 07:05AM Chiasma Reports First Quarter Financial Results and Announced Agreement to Merge with Amryt

May 5, 2021 07:01AM Amryt Pharma (AMYT) to Acquire Chiasma (CHMA) in all-stock deal

May 5, 2021 07:00AM Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases

May 5, 2021 07:00AM Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases

Apr 29, 2021 08:00AM Chiasma to Report First Quarter Financial Results on May 6, 2021

Mar 22, 2021 04:05PM Chiasma Inc. (CHMA) Presents Long-Term Safety and Efficacy Data from Open-Label Extension Study of its CHIASMA OPTIMAL Phase 3 Trial Evaluating MYCAPSSA in Patients with Acromegaly at ENDO

Mar 22, 2021 04:01PM Chiasma Presents Long-Term Safety and Efficacy Data from the Open-Label Extension Study of its CHIASMA OPTIMAL Phase 3 Trial Evaluating MYCAPSSA® in Patients with Acromegaly at ENDO 2021

Mar 22, 2021 05:57AM Chiasma Inc. (CHMA) Reports New Positive Data for MYCAPSSA from Phase 3 Trial MPOWERED at ENDO 2021 Meetings

Mar 20, 2021 11:00AM Chiasma Presents New Positive Data for MYCAPSSA from Phase 3 Trial MPOWERED™ for the Maintenance Treatment of Acromegaly at ENDO 2021

Mar 10, 2021 08:00AM Chiasma to Present New Data from Two Phase 3 Trials, CHIASMA OPTIMAL and MPOWERED™, at ENDO 2021

Mar 4, 2021 04:01PM Chiasma Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Corporate Update

Mar 2, 2021 08:00AM Chiasma to Participate in the H.C. Wainwright Global Life Sciences Conference

Feb 25, 2021 08:00AM Chiasma to Report Fourth Quarter 2020 Results on March 4

Jan 19, 2021 07:03AM Chiasma Inc. (CHMA) Announces Hiring of John Doyle as CFO

Jan 19, 2021 07:00AM Chiasma Announces Hiring of John Doyle as Chief Financial Officer

Jan 6, 2021 04:09PM Chiasma (CHMA) Provides Corporate Update and Previews Expected 2021 Milestones

Jan 6, 2021 04:01PM Chiasma Provides Corporate Update and Previews Expected 2021 Milestones

Nov 23, 2020 08:00AM Chiasma to Participate in Two Investor Conferences in December

Nov 20, 2020 08:00AM Chiasma to Host an Expert Panel on Acromegaly and the MPOWERED® Phase 3 Trial Results

Nov 18, 2020 07:10AM Chiasma Inc. (CHMA) Announces Positive Topline Results from the MPOWERED Phase 3 Clinical Trial Comparing MYCAPSSA to Long Acting Injectables for the Maintenance Treatment of Adults with Acromegaly

Nov 18, 2020 07:00AM Chiasma Announces Positive Topline Results from the MPOWERED™ Phase 3 Clinical Trial Comparing MYCAPSSA® (octreotide capsules) to Long Acting Injectables for the Maintenance Treatment of Adults wit

Nov 16, 2020 08:00AM Chiasma to Participate in the Jefferies Virtual London Healthcare Conference

Nov 5, 2020 04:05PM Chiasma Reports Third Quarter 2020 Results and Provides MYCAPSSA Launch Update

Oct 30, 2020 08:00AM Chiasma Reinforces Commitment to People with Acromegaly and Advocacy Organizations on Acromegaly Awareness Day

Oct 29, 2020 08:00AM Chiasma to Report Third Quarter 2020 Results on November 5

Oct 1, 2020 07:09AM Chiasma Inc. (CHMA) Announces Planned Transition of Former CEO

Oct 1, 2020 07:00AM Chiasma Announces Planned Transition of Former CEO

Sep 8, 2020 08:00AM Chiasma to Participate in Two September Investor Conferences

Aug 31, 2020 08:00AM Chiasma Announces U.S. Commercial Launch and Availability of MYCAPSSA®, the First and Only Oral Somatostatin Analog for Patients with Acromegaly

Aug 17, 2020 08:03AM Chiasma Inc. (CHMA) Announces Publication of Pivotal Data from Phase 3 CHIASMA OPTIMAL Clinical Trial in the Journal of Clinical Endocrinology & Metabolism

Aug 17, 2020 08:00AM Chiasma Announces Publication of Pivotal Data from the Phase 3 CHIASMA OPTIMAL Clinical Trial in the Journal of Clinical Endocrinology & Metabolism

Aug 10, 2020 04:05PM Chiasma Reports Second Quarter 2020 Results and Significant Progress on Launch Preparedness

Aug 3, 2020 04:01PM Chiasma to Report Second Quarter 2020 Results on August 10

Jul 27, 2020 04:25PM Chiasma (CHMA) Announces 48-Week Safety, Efficacy Data from Open-Label Extension Study of its CHIASMA OPTIMAL Phase 3 Trial Evaluating MYCAPSSA in Patients with Acromegaly

Jul 27, 2020 04:01PM Chiasma Announces 48-Week Safety and Efficacy Data from the Open-Label Extension Study of its CHIASMA OPTIMAL Phase 3 Trial Evaluating MYCAPSSA® in Patients with Acromegaly

Jul 1, 2020 09:05AM Chiasma Inc. (CHMA) Announces Pricing of Public Offering of $70 Million of Common Stock and Pre-Funded Warrants

Jul 1, 2020 09:05AM Chiasma Announces Pricing of a Public Offering of $70 Million of Common Stock and Pre-Funded Warrants

Jun 30, 2020 04:31PM Chiasma Inc. (CHMA) Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Jun 30, 2020 04:30PM Chiasma Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Jun 26, 2020 01:29PM Chiasma Inc. (CHMA) Announces FDA Approval of MYCAPSSA

Jun 26, 2020 01:28PM Chiasma Announces FDA Approval of MYCAPSSA® (Octreotide) Capsules, the First and Only Oral Somatostatin Analog

May 7, 2020 04:05PM Chiasma Reports First Quarter 2020 Financial Results

Apr 30, 2020 04:01PM Chiasma To Report First Quarter Financial Results On May 7, 2020

Apr 22, 2020 04:45PM Chiasma Appoints Anand Varadan as Chief Commercial Officer and Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

Apr 8, 2020 07:00AM Chiasma Enters Into Revenue Interest Financing Agreement for up to $75 Million with Healthcare Royalty Partners

Mar 16, 2020 04:05PM Chiasma Reports Fourth Quarter and Full Year 2019 Financial Results

Mar 9, 2020 04:05PM Chiasma To Report Fourth Quarter and Full Year 2019 Financial Results On March 16, 2020

Jan 13, 2020 07:08AM Chiasma Inc. (CHMA) Reports FDA Acceptance of MYCAPSSA New Drug Application Resubmission

View Older Stories